The Latest
Partner Therapeutics Announces Publication of Results From the eNRGy Trial of Zenocutuzumab in Patients with NRG1+ Cholangiocarcinoma in Journal of Clinical Oncology (JCO)
Partner Therapeutics announced publication of the eNRGy trial results of Zenocutuzumab in NRG1+ cholangiocarcinoma, highlighting potential treatment implications.